Why the study?
Pulmonary vascular resistance plays a major role in congenital heart disease management and critical decisions, highlighting the importance of evaluating its basic calculation and interpretation.
This review highlights the importance of accurate pulmonary vascular resistance measurement and calculation via invasive cardiac catheterization in the management of congenital heart disease.
Answers are grounded in this paper and cite their sources.
Requires cautious PVR interpretation in congenital interventions; leaves open prospective validation of standardized protocols.
Pulmonary vascular resistance (PVR) plays a major role in congenital heart management and critical decision. The impact of pulmonary vascular disease in the early and late morbidity and mortality after cardiac surgery and interventional catheterization in congenital heart defect (CHD) highlights the importance of critical evaluation for PVR. Currently, PVR is evaluated with invasive cardiac catheterization for hemodynamic data collection, processing, and analysis. Despite the limitation of hemodynamic evaluation in the setting of CHD, accurate data analysis, and interpretation have significant impact on clinical outcome and procedure success. This article reviews the basic calculation of PVR in the setting of congenital heart disease with diagrammatic illustration for easy understanding of the hemodynamic.
No takes yet. Share an insight, caveat, or question.
Tamimi et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: